SUCCINYLCHOLINE CHLORIDE INJECTION USP DIN 02422336
Health Canada record
| Active ingredient(s) | SUCCINYLCHOLINE CHLORIDE 20 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M03AB01 SUXAMETHONIUM |
| Original market date | 30-Sep-2014 |
| Current status date | 22-Apr-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Hikma Canada Limited — licence 3-002579, currently licensed, last inspection rating C (2022-04-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SUCCINYLCHOLINE CHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00038172 | QUELICIN | PFIZER CANADA ULC | Solution | SUCCINYLCHOLINE CHLORIDE 20 MG | Marketed |
| 02501783 | SUCCINYLCHOLINE CHLORIDE INJECTION, USP | DR REDDY'S LABORATORIES LTD | Solution | SUCCINYLCHOLINE CHLORIDE 20 MG | Marketed |
| 00068330 | ANECTINE FLOPACK 500MG | GLAXO WELLCOME INC. | Powder For Solution | SUCCINYLCHOLINE CHLORIDE 500 MG | Cancelled Post Market |
| 00268305 | ANECTINE INJ 20MG/ML | GLAXO WELLCOME INC. | Liquid | SUCCINYLCHOLINE CHLORIDE 20 MG | Cancelled Post Market |
| 00296163 | QUELICIN | PFIZER CANADA ULC | Solution | SUCCINYLCHOLINE CHLORIDE 100 MG | Cancelled Post Market |
| 00640778 | QUELICIN INJ 20MG/ML USP | ABBOTT LABORATORIES, LIMITED | Solution | SUCCINYLCHOLINE CHLORIDE 20 MG | Cancelled Post Market |
| 02062232 | SUCCINYLCHOLINE CHLORIDE INJECTION USP | MYLAN PHARMACEUTICALS ULC | Solution | SUCCINYLCHOLINE CHLORIDE 20 MG | Cancelled Pre Market |
| 02300419 | SUCCINYLCHOLINE CHLORIDE INJECTION, USP 20MG/ML | ALVEDA PHARMACEUTICALS INC | Liquid | SUCCINYLCHOLINE CHLORIDE 20 MG | Cancelled (Unreturned Annual) |
International API supply for SUCCINYLCHOLINE CHLORIDE
5 active FDA Drug Master Files.
Request a quote for SUCCINYLCHOLINE CHLORIDE INJECTION USP